🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 76152G118
- Market Cap
- Micro Cap
- Previous Symbol
- TZACW (changed 12/15/2020)
- Previous Name
- Tenzing Acquisition Corp
- Parent Company
- Tenzing Acquisition Corp (RVPH)
Business: Reviva Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary focus is developing its lead product candidate, RP5063 (brilaroxazine), for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.
Notes: Each warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per share, subject to adjustment.Each warrant will become exercisable on the later of the completion of an initial business combination and 12 months from the date of this prospectus, and will expire five years after the completion of an initial business combination, or earlier upon redemption.
Company Contact
- CEO
- Laxminarayan Bhat
- CFO
- Narayan Prabhu
- Headquarters
- 19925 Stevens Creek Blvd., Suite 100, Cupertino, CA 95014
- Phone
- 408-501-8881
- Investor Relations
- Bruce Mackle, LifeSci Advisors LLC. · 929-469-3859 · bmackle@lifesciadvisors.com